Dr. Bharat Kwatra Comp. Precision Oncology
Clinical service

Longitudinal Molecular Monitoring

Interpretation of molecular change over time rather than at a single point.

Who it is for
  • Patients with serial molecular or ctDNA results.
  • Clinicians tracking molecular evolution during or after therapy.
What is reviewed
  • Serial molecular and ctDNA results
  • Treatment timeline and documented response
  • Emergence or disappearance of specific alterations
What is delivered
  • Interpretation of the molecular trajectory
  • Notes on possible resistance mechanisms where the data supports them
  • Considerations for continued monitoring
How this works alongside your care
  • Analysis and interpretation are provided to you and, where you wish, directly to your treating team — who continue to prescribe, administer and direct your treatment.
  • The work sits alongside your treating oncologist and is designed to strengthen that relationship rather than sit outside it.
  • It is built for considered review. Anything acute or time-critical belongs with your treating team or your local emergency service, who can act immediately.
  • It sets out what the evidence supports and where it remains uncertain. It does not forecast how a particular cancer will respond.
How to begin

Getting started

Nothing is charged for an enquiry, and scope is agreed in writing before any work starts.

Enquiries begin with a short message describing the situation and the question. From there, the documentation needed is agreed, and a scope and timeline are confirmed before any work starts.

The document checklist sets out what is typically needed. Missing items are worth identifying at the outset rather than mid-review.

Begin Document checklist
Book a consultation

Talk it through before you decide

Monday to Saturday, 12:00 – 18:00 · by appointment at KPCIRC, Paschim Vihar. Remote review available for patients and clinicians elsewhere.

WhatsApp